Skip to main content

Table 5 Comparison of clinicopathological parameters of 97 locally advanced esophageal squamous cell carcinoma patients who received curative concurrent chemoradiotherapy according to VEGF day 28/day 5 ratio

From: The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy

Characteristics Day 28/Day5 ratio < 1 group (N = 45) Day 28/Day5 ratio > 1 group (N = 52) P value
Age
  < 60 years 29 (64%) 35 (67%) 0.77
  ≥ 60 years 16 (36%) 17 (33%)  
T status
 1 + 2 8 (18%) 7 (14%) 0.56
 3 + 4 37 (82%) 45 (86%)  
N status
 0 + 1 14 (31%) 17 (33%) 0.87
 2 + 3 31 (69%) 35 (67%)  
Stage
 II + IIIA + IIIB 17 (38%) 15 (29%) 0.35
 IIIC 28 (62%) 37 (71%)  
Grade
 1 + 2 35 (78%) 36 (69%) 0.34
 3 10 (22%) 16 (31%)  
Location
 Upper 22 (49%) 18 (35%) 0.15
 Middle + Lower 23 (51%) 34 (65%)  
  1. VEGF vascular endothelial growth factor